Introduction {#sec1_1}
============

Intracerebral hemorrhage (ICH) accounts for about 15% of stroke cases and is associated with a 30-day mortality rate exceeding 30% \[[@B1]\]. Poor outcome in ICH patients has been linked to the neurologic deterioration seen with hematoma expansion \[[@B2]\]. Low low-density lipoprotein (LDL) and platelet inhibition, independent of hypertension, have been associated with hematoma expansion \[[@B3],[@B4],[@B5],[@B6]\].

Consumption of excess alcohol has been linked to an increased risk of hemorrhagic stroke \[[@B7],[@B8],[@B9]\]. To our knowledge, in the setting of normal liver function tests, there are no studies that have systematically evaluated the relationship between daily alcohol use and hematoma expansion. In studies investigating the relationship between low LDL levels and ICH, a total cholesterol level of \<150 mg/l in the presence of active statin use was associated with greater hemorrhage volume and worse outcomes compared to statin users with higher cholesterol \[[@B10]\]. Another study found that LDL-cholesterol levels \<95 mg/dl were associated with increased hemorrhagic growth without significant difference in pre-ICH statin exposure in patients with and without hematoma growth \[[@B11]\].

Since a low LDL level and platelet inhibition have been independently shown to enhance hematoma expansion, we hypothesized that (1) patients who consumed alcohol daily would be more likely to experience hematoma expansion, and (2) patients with low LDL levels who consumed alcohol daily would be particularly prone to hematoma expansion.

Methods {#sec1_2}
=======

A retrospective, observational study was performed on consecutive patients admitted to the Tulane Stroke Center, New Orleans, La., USA, with spontaneous ICH from July 2008 to July 2013. These patients were identified through our prospectively collected stroke registry. Patients were excluded if neurosurgical evacuation of the ICH was performed or the history of alcohol use was not clearly documented. They were not excluded for home use of anticoagulant or an elevated international normalized ratio on coagulation testing. Patients were divided into two groups: daily alcohol users and non-daily alcohol users. Daily alcohol use was defined as consumption of two or more alcohol equivalents on a daily basis, as reported by the patient and/or patient representative. The electronic medical record was reviewed to abstract current alcohol exposure.

Registry data included age, gender, race, initial blood pressure (BP), hypertensive history and medication compliance, Glasgow Coma Scale (GCS) score on initial evaluation, ICH score, National Institute of Health Stroke Scale (NIHSS) score as assessed by a NIHSS-certified healthcare provider, laboratory values, including blood counts, coagulation profile, and lipid panel, ICH volume and volume growth at 24 h, discharge modified Rankin Scale (mRS) score, discharge disposition, and in-hospital mortality. All patients were admitted to the neurological intensive care unit. Lipids were measured after 12 h of fasting, but within 48 h of presentation.

ICH volume was calculated on baseline and follow-up computed tomography (CT) scans of the head using the ABC/2 method \[[@B12]\]. ICH score grading was performed at the time of admission by the admitting neurology resident and confirmed by a board certified vascular neurologist. Significant hematoma expansion was defined as an increase in volume by ≥33% \[[@B13]\] at 24 h. Patients with hypertension, the primary etiology of spontaneous ICH, are at best with a moderate risk for cardiovascular and cerebrovascular events; therefore, we dichotomized the LDL level at 100 mg/dl based on the recommendation of the National Cholesterol Education Program Adult Treatment Panel. Functional outcome at the time of discharge was determined by a physician certified in the mRS score. Our primary end point was significant (≥33%) hematoma expansion, and our secondary end point was any hematoma expansion.

Continuous variables without substantial deviations from a normal distribution were reported as means ± standard deviation, and differences between the daily alcohol and non-daily alcohol users were analyzed with Satterthwaite\'s approximate t test. Continuous variables with non-normal distributions were reported as medians with ranges and analyzed with Wilcoxon\'s two-sample test for two-sided normal approximation. Categorical variables were analyzed using the χ^2^ test. The association between significant (≥33%) hematoma expansion and daily alcohol use was modeled using logistic regression, while the association between hematoma expansion and daily alcohol use was modeled using linear regression. The regression models were repeated for the same outcomes using daily alcohol use in the setting of LDL \<100 as the exposure. The relationship between ICH growth and LDL was modeled using a general linear model. As this was an exploratory analysis, no adjustments were made for multiple comparisons \[[@B14]\]. All tests were performed at a significance level of α = 0.05. This study was approved by our Institutional Review Board.

Results {#sec1_3}
=======

Comparison of Patients with ICH in Daily Alcohol Users and Patients Who Do Not Consume Alcohol Daily {#sec2_1}
----------------------------------------------------------------------------------------------------

Of the 252 patients admitted with spontaneous ICH, 226 met criteria, of whom 20.4% had a history of daily alcohol use. The average age was 61 years (range 19-94), 55.6% of the patients were males, and 67.1% were of African American origin. Those who were excluded for neurosurgical evacuation (n = 13) or undocumented alcohol use (n = 13) were not statistically different from those who were included with regard to GCS (p = 0.1035) or baseline NIHSS (p = 0.0883), but they had higher initial volumes (34 vs. 10 ml, p = 0.0195). When compared to non-daily alcohol users, daily alcohol users were more likely to be of male gender (80.4 vs. 50.6%, p = 0.0003), and to have a higher median BP upon admission (systolic BP of 190 vs. 173 mm Hg, p = 0.0342; diastolic BP of 115 vs. 110 mm Hg, p = 0.0052). Daily alcohol users were less likely to be taking BP medication at home (34.8 vs. 58.1%, p = 0.0138) despite similar frequency of hypertension (69.6 vs. 85.0%, p = 0.0623). As demonstrated in table [1](#T1){ref-type="table"}, there were no significant differences in race, mean LDL, mean triglycerides, use of anticoagulation or international normalized ratio, baseline GCS, or NIHSS in daily alcohol versus non-daily alcohol patients. Daily alcohol users had lower platelet counts than non-daily users (191 vs. 226, p = 0.0051). There were no significant differences in baseline or follow-up ICH volume, rate of intraventricular hemorrhage, external ventricular drain placement, hydrocephalus, supratentorial location or ICH scores (table [1](#T1){ref-type="table"}). No significant differences in significant hematoma expansion, any hematoma expansion, or mean volume increase were found. Furthermore, there were also no significant differences in mean time to follow-up CT, discharge NIHSS, discharge mRS, discharge disposition, or in-hospital mortality, but lengths of stay was significantly prolonged in patients consuming daily alcohol (11 vs. 7, p = 0.0156) (table [2](#T2){ref-type="table"}).

The crude model found a nonsignificant association between daily alcohol use and \>33% hematoma expansion (OR = 1.26, 95% CI 0.55-2.86, p = 0.5858). Adjusting for gender, home BP medication use, and admission platelet count, the association remained, but was nonsignificant (OR = 1.48, 95% CI 0.36-6.17, p = 0.5874). The crude linear model did not find a significant association between hematoma expansion and daily alcohol use (β = 5.4, SE = 15.9, p = 0.7356). After adjusting for differences between groups (gender, home BP medication use, admission platelet count), this remained nonsignificant (β = 3.3, SE = 7.8, p = 0.6742).

Comparison of Patients with ICH Who Use Alcohol Daily with Low versus High LDL Levels {#sec2_2}
-------------------------------------------------------------------------------------

LDL was not measured in 6 patients with chronic daily alcohol use and ICH, leaving 40 patients for comparison based on LDL dichotomized (20 patients with LDL \<100 mg/dl and 20 patients with LDL ≥100 mg/dl). Daily alcohol users with a low LDL level (\<100 mg/dl) were not significantly different from those with a high LDL level with respect to baseline demographics, history of hypertension, admission BP, prothrombin time, or platelet count. Daily alcohol users with a low LDL level had insignificantly larger median baseline ICH volumes (11 vs. 7 ml, p = 0.2479) and ICH scores (2 vs. 1, p = 0.1671), but the frequencies of intraventricular hemorrhage and hydrocephalus were not significantly different in the two groups (table [3](#T3){ref-type="table"}). As demonstrated in table [4](#T4){ref-type="table"}, there was no difference in rate of significant (≥33%) hematoma expansion at 24 h (25 vs. 21%, p = 0.3245) or any hematoma expansion (83.3 vs. 84.2%, p = 0.3764). Follow-up volumes (14.5 vs. 10 ml, p = 0.0676) and mean volume increase (1 vs. 0.5 h, p = 0.2531) were larger in patients with low LDL levels. No difference in discharge disposition or discharge NIHSS score was found. There were also no significant differences in mean time to follow-up CT, lengths of stay, discharge mRS and inpatient mortality rate.

The crude model found a nonsignificant association between hematoma expansion and low LDL levels in daily alcohol users (β = 1.7, SE = 13, p = 0.8966). After adjusting for initial ICH volume, this finding remained nonsignificant (β = −1.5, SE = 14.3, p = 0.5730). Overall, ICH growth increased with progressively lower LDL measurements (fig. [1](#F1){ref-type="fig"}).

Discussion {#sec1_4}
==========

To the best of our knowledge, this is the first study to evaluate the relationship between daily alcohol intake, LDL and hematoma expansion. Previous studies have shown an association between heavy drinking and risk of ICH, but no current studies investigate hematoma expansion \[[@B15],[@B16],[@B17]\]. While we hypothesized that patients who consumed alcohol daily would be more likely to experience hematoma expansion, we did not find such an association between alcohol use and baseline or subsequent ICH volumes. We also failed to detect hematoma expansion amongst patients with low LDL levels who consumed alcohol daily compared to alcohol users who had high LDL levels.

Alcohol has been shown to lower the LDL level \[[@B18]\]. In our sample, the mean LDL level among daily alcohol users was similar to patients who did not report daily alcohol consumption. We were unable to identify predictors of low LDL levels among alcohol users, possibly due to incomplete information on the actual grams of alcohol consumed on a daily basis and baseline nutritional status. Despite statistically significant difference in platelet count, the median platelet counts in the two groups were both within the normal range and not likely clinically meaningful. Furthermore, there was no difference in hematoma expansion, by any definition, comparing the chronic daily alcohol patients when the LDL level was not considered.

The impact of alcohol on BP elevation has been well described \[[@B6],[@B19],[@B20],[@B21]\]. In our sample, daily alcohol users had a higher systolic and diastolic BP upon admission. They reported taking their home BP medications less frequently than non-daily alcohol users. In addition, alcohol misuse may lead to medication noncompliance. In our sample, daily alcohol users presented with higher proportions of medication noncompliance and higher BP. Previous studies have shown that alcohol consumption reduces the protective effects of higher education \[[@B22]\].

Some epidemiological studies have reported that low cholesterol is associated with a higher incidence of ICH \[[@B23]\]. However, intensive lowering of cholesterol with high-dosed statins does not appear to increase the risk of ICH \[[@B24]\]. Prior studies investigating the risk of hemorrhagic transformation following an ischemic stroke have shown that a lower LDL level and total cholesterol are associated with an increased risk of hemorrhagic transformation \[[@B25]\]. We were unable to evaluate the potential association with statin use and hematoma expansion, since only three of our daily alcohol users were taking a statin prior to admission.

Our study had a number of limitations. It reflects a single center experience with a small number of patients, raising concern for generalizability. Our sample size may have impaired our ability to detect statistically significant differences between groups. We may have not been able to capture accurate social history on some of our sicker patients and others may have simply withheld information. We were unable to reliably quantify the alcohol use; therefore, we cannot determine a dose-response relationship with ICH growth, nor evaluate the relationship of binge drinking on ICH. Patients with daily alcohol use had higher baseline BP; therefore, it is possible that difficulties in controlling the BP in the first 24 h confounded assessment of the hematoma expansion. Our admission order sets are standardized to include parameters and antihypertensive medications to maintain parameters, with physician call orders if parameters cannot be maintained. Use of the ABC/2 method, rather than semi-automated methods for measuring ICH volume, confers a degree of inaccuracy which may have impacted the validity of our findings \[[@B26]\]. Finally, we did not limit the study population to patients presenting in the first 6 h of symptom onset, when hematoma expansion is most likely to occur (last seen normal time unknown, n = 49; presentation within 6 h of symptom onset, n = 121).

Conclusion {#sec1_5}
==========

Our study demonstrated no evidence to support that daily alcohol use with or without low LDL levels contributes to hematoma expansion after admission for spontaneous ICH. A larger prospective study, restricting the sample to patients presenting during the first hours when the risk for continued bleeding is high, is needed to further assess the relationships between alcohol use, LDL level, ICH volume and hematoma expansion.
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###### 

Baseline demographics and patient characteristics in the total patient sample

  Variable                                Daily alcohol users (n = 46)   Non-daily alcohol users (n = 180)   p value
  --------------------------------------- ------------------------------ ----------------------------------- ---------
  Median age, years                       60 (29 -- 92)                  62 (19 -- 94)                       0.1116
  Male gender, n                          37 (80.4)                      91 (50.6)                           0.0003
  African American race, n                29 (67.4)                      118 (66.7)                          0.3009
  History of hypertension, n              32 (69.6)                      146 (85)                            0.0623
  Taking antihypertensive medication, n   16 (34.8)                      104 (58.1)                          0.0138
  Median baseline SBP, mm Hg              190 (136 -- 320)               173 (103 -- 280)                    0.0342
  Median baseline DBP, mm Hg              115 (71 -- 180)                100 (49 -- 177)                     0.0052
  Median baseline GCS                     15 (3 -- 15)                   14 (3 -- 15)                        0.7437
  Median baseline NIHSS                   15 (0 -- 40)                   13 (0 -- 40)                        0.8887
  Median LDL, mg/dl                       97 (19 -- 217)                 101 (34 -- 245)                     0.4794
  Median triglycerides, mg/dl             99 (34 -- 216)                 97 (32 -- 511)                      0.5426
  Median platelet count                   191 (41 -- 766)                226 (98 -- 793)                     0.0051
  Warfarin use on admission, %            2 (4.3)                        20 (11.1)                           0.2630
  Median prothrombin time                 11.2 (9.4 -- 39.4)             10.9 (9.6 -- 63.2)                  0.5653
  Median prothromboplastin time           25.3 (19.3 -- 35.1)            24.9 (18.6 -- 65.4)                 0.1509
  Median baseline ICH volume, ml          9 (0 -- 72)                    9.1 (0 -- 186)                      0.8183
  Median ICH score                        1 (0 -- 4)                     1 (0 -- 6)                          0.4794
  Supratentorial location, n              40 (86.9)                      143 (79.9)                          0.2725
  IVH, n                                  20 (43.5)                      77 (42.8)                           0.9317
  Hydrocephalus, n                        10 (21.7)                      52 (28.9)                           0.3321
  Ventriculostomy, n                      8 (17.4)                       20 (11.1)                           0.2486

Values in parentheses are percentages or ranges.

###### 

Patient outcomes of daily alcohol users versus non-daily alcohol users

  Outcomes                          Daily alcohol users (n = 46)   Non-daily alcohol users (n = 180)   p value
  --------------------------------- ------------------------------ ----------------------------------- ---------
  Median follow-up ICH volume, ml   10 (1 -- 167)                  10 (0 -- 402)                       0.8545
  Median time to follow-up CT, h    7 (3 -- 28)                    7.8 (4.5 -- 30.5)                   0.5123
  Mean volume increase, ml          1 (−1.3 to 138.5)              0 (−13 to 346)                      0.1482
  Volume increase by ≥33, n         10 (27)                        33 (22.8)                           0.5854
  Median length of stay, days       11 (1 -- 86)                   7 (1 -- 53)                         0.0156
  Median discharge NIHSS            8 (0 -- 42)                    10 (0 -- 42)                        0.8228
  Median discharge mRS              4 (0 -- 6)                     4 (0 -- 6)                          0.9193
  Death, n                          8 (17.4)                       36 (20)                             0.6901
  Disposition, n                                                                                       0.4856
   Home                             10 (22.7)                      41 (24.4)                           
   Inpatient rehabilitation         12 (27.3)                      26 (15.5)                           
   Skilled nursing/nursing home     3 (6.9)                        8 (4.8)                             
   Long-term acute care             1 (2.3)                        5 (2.9)                             
   Hospice                          0                              1 (0.6)                             

Values in parentheses are percentages or ranges.

###### 

Characteristics of daily alcohol users with low versus high LDL

  Characteristics                         Daily alcohol users with LDL \<100 (n = 20)   Daily alcohol users with LDL ≥100 (n = 20)   p value
  --------------------------------------- --------------------------------------------- -------------------------------------------- ---------
  Median age, years                       61 (29 -- 92)                                 52 (39 -- 79)                                0.2549
  Male gender, n                          19 (95)                                       15 (75)                                      0.5468
  African American race, n                14 (70)                                       17 (85)                                      0.2464
  History of hypertension, n              14 (70)                                       18 (90)                                      0.0515
  Taking antihypertensive medication, n   10 (50)                                       7 (35)                                       0.5049
  Median baseline SBP, mm Hg              180 (136 -- 320)                              218 (140 -- 248)                             0.2307
  Median baseline DBP, mm Hg              103 (74 -- 180)                               123 (85 -- 170)                              0.1418
  Median baseline GCS                     13 (3 -- 15)                                  15 (4 -- 15)                                 0.1002
  Median baseline NIHSS                   16 (0 -- 38)                                  13 (0 -- 33)                                 0.4441
  Median triglycerides, mg/dl             92 (34 -- 333)                                118 (50 -- 216)                              0.1331
  Median platelet count                   198 (112 -- 766)                              205 (41 -- 370)                              0.7415
  Median prothrombin time                 11.3 (9.8 -- 30.5)                            11.1 (9.4 -- 39.4)                           0.5691
  Median prothromboplastin time           24.5 (20.6 -- 31.3)                           24.6 (19.3 -- 35.1)                          0.2235
  Supratentorial location, n              20 (100)                                      16 (80)                                      0.0167
  Median baseline ICH volume, ml          11 (0 -- 90.8)                                7 (1 -- 32)                                  0.2479
  IVH, n                                  10 (50)                                       8 (40)                                       0.2261
  Hydrocephalus, n                        6 (30)                                        5 (25)                                       0.2678
  Median ICH score                        2 (0 -- 4)                                    1 (0 -- 3)                                   0.1671
  Ventriculostomy, n                      5 (25)                                        5 (25)                                       0.2760

Values in parentheses are ranges or percentages.

###### 

Patient outcomes of daily alcohol users with low versus high LDL

  Outcomes                          Daily alcohol users with LDL \<100 (n = 20)   Daily alcohol users with LDL ≥100 (n = 20)   p value
  --------------------------------- --------------------------------------------- -------------------------------------------- ---------
  Median follow-up ICH volume, ml   14.5 (1.5 -- 89.3)                            10 (1 -- 68)                                 0.0676
  Median time to follow-up CT, h    7 (3.5 -- 28)                                 7 (5 -- 13)                                  0.8463
  Mean volume increase, h           1 (−1.5 to 21.9)                              0.5 (−1.3 to 43)                             0.2531
  Volume increase \>0, n            10/12 (83.3)                                  16/19 (84.2)                                 0.3764
  Volume increase by ≥33, n         3/12 (25)                                     4/19 (21.1)                                  0.3245
  Median length of stay, days       9.5 (1 -- 86)                                 11 (3 -- 40)                                 0.2549
  Median discharge NIHSS            11 (0 -- 42)                                  10 (0 -- 42)                                 0.8181
  Median discharge mRS              5 (0 -- 6)                                    4 (0 -- 6)                                   0.2321
  Death, n                          6 (30)                                        2 (10)                                       0.1311
  Disposition, n                                                                                                               0.1877
   Home                             3/14 (15.8)                                   6/14(31.6)                                   
   Inpatient rehabilitation         9/14 (47.4)                                   2/14 (10.5)                                  
   Skilled nursing/nursing home     1/14 (5.3)                                    1/14 (5.3)                                   
   Long-term acute care             1/14 (5.3)                                    1/14 (5.3)                                   
   Hospice                          0                                             1/14 (5.3)                                   

Values in parentheses are percentages or ranges
